首页|罗哌卡因复合舒芬太尼腰硬联合麻醉用于妊娠期高血压疾病剖宫产术的疗效观察

罗哌卡因复合舒芬太尼腰硬联合麻醉用于妊娠期高血压疾病剖宫产术的疗效观察

扫码查看
目的 观察罗哌卡因复合舒芬太尼腰硬联合麻醉用于妊娠期高血压疾病剖宫产术的疗效.方法 选取本院2014年1月~2015年1月妊娠期高血压疾病剖宫产术的产妇共77例,随机分为观察组39例和对照组38例,对照组给予罗哌卡因麻醉,观察组给予罗哌卡因复合舒芬太尼腰硬麻醉,观察2组产妇麻醉起效时间、手术时间、镇痛维持时间、新生儿apgar评分、术后疼痛评分和不良反应情况.结果 ①观察组麻醉起效时间、镇痛维持时间和术后疼痛评分均明显优于对照组,且差异有统计学意义(P<0.05);②2组产妇在手术时间、新生儿apgar评分和不良反应总发生率上差异均无统计学意义.结论 罗哌卡因复合舒芬太尼腰硬联合麻醉用于妊娠期高血压疾病剖宫产术的麻醉效果确切,效果优于单独应用罗哌卡因的腰麻方案,且无明显不良反应,值得临床进一步推广和应用.
Efficacy of palace production technique of puerpera with gestational hypertension by ropivacaine combined with sufentanil and epidural anesthesia
Objective To observe the efficacy of palace production technique of Puerpera with gestational hypertension by ropivacaine combined with sufentanil and epidural anesthesia.Methods77 cases with hypertensive disorders in pregnancy from January 2014 to January 2015 hypertensive, 39 cases were randomly divided into observation group and the control group of 38 patients, the control group received ropivacaine anesthesia, the observation group received ropivacaine combined with sufentanil and epidural anesthesia, observed two groups of mothers onset time of anesthesia, operative time, pain duration, neonatal apgar score, postoperative pain scores and adverse reactions.ResultsThe onset time of anesthesia, analgesia duration, and postoperative pain scores were significantly better than the control group, the difference was significant (P<0.05);two groups of mothers in the operation time, score and adverse neonatal apgar, the total incidence the difference was not statistically significant.ConclusionRopivacaine combined with sufentanil CSEA anesthesia for hypertensive disorders in pregnancy cesarean exact effect is better than alone ropivacaine spinal anesthesia program, and no obvious side effects and is worthy of further promotion and application.

ropivacaineepidural sufentanilanesthesiagestational hypertension

王莉、仰紫景、胡颖

展开 >

浙江省桐庐县第一人民医院 麻醉科,浙江 杭州 311500

罗哌卡因 舒芬太尼腰硬 联合麻醉 妊娠期高血压疾病剖宫产术

2017

中国生化药物杂志
南京生物化学制药研究所,全国生化制药情报中心站,中国生化制药工业协会,中国药品生物制品检定所

中国生化药物杂志

ISSN:1005-1678
年,卷(期):2017.37(6)
  • 31
  • 10